Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kulkarni, Roshni
B-Natural, NCT02502409: Natural History Study of Factor IX Treatment and Complications	Active, not recruiting	N/A	550	US	Standard care with blood and urine sample collection	Skane University Hospital, Indiana Hemophilia &Thrombosis Center, Inc., Bioverativ Therapeutics Inc., Swedish Orphan Biovitrum	Factor IX Deficiency	06/19	12/21
NCT03853486: ATHN 9: Severe VWD Natural History Study	Active, not recruiting	N/A	108	US		American Thrombosis and Hemostasis Network, Takeda	Von Willebrand Diseases	12/24	01/25
PRESent-5, NCT05605678: Hemophilia Non-Interventional Study Prior to SerpinPC Intervention	Recruiting	N/A	200	Europe, Canada, US, RoW	No Intervention	ApcinteX Ltd, Centessa Pharmaceuticals plc	Hemophilia A, Hemophilia B	11/24	11/24